Inventor · disambiguated record
Keisuke Imamura
Also filed as: IMAMURA KEISUKE
18 granted patents·4 pending applications·60 citations·filing 2011–2025
92Inventor score
Top patents by PatentIndex Score
22 records- 0197US10428023B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Oct 1, 2019·22 cites·1 claims
- 0296US10584097B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Mar 10, 2020·14 cites·1 claims
- 0394US11440883B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Sep 13, 2022·3 cites·1 claims
- 0489US10577382B2Fused heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Mar 3, 2020·3 cites·11 claims
- 0587US11319286B2Heterocyclic compound and application thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted May 3, 2022·4 cites·10 claims
- 0686US2024360080A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 0784US11655241B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted May 23, 2023·2 cites·15 claims
- 0880US12421188B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 23, 2025·0 cites·19 claims
- 0980US12415782B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 16, 2025·0 cites·19 claims
- 1080US12404237B2Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivativesTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 2, 2025·0 cites·19 claims
- 1178US8563575B2Fused heterocyclic compoundsTANIGUCHI TAKAHIKO·Filed 2011·Granted Oct 22, 2013·4 cites·15 claims
- 1276US10981934B2Fused heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Apr 20, 2021·1 cites·5 claims
- 1376US2023063805A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1475US8940758B2Fused heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Jan 27, 2015·2 cites·17 claims
- 1575US8846713B2Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitorsTANIGUCHI TAKAHIKO·Filed 2011·Granted Sep 30, 2014·2 cites·2 claims
- 1675US2021276949A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1774US9226921B2Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitorsTAKEDA PHARMACEUTICAL·Filed 2014·Granted Jan 5, 2016·2 cites·17 claims
- 1870US11390634B2Fused heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jul 19, 2022·0 cites·10 claims
- 1965US9029388B2Condensed heterocyclic compoundTANIGUCHI TAKAHIKO·Filed 2012·Granted May 12, 2015·1 cites·13 claims
- 2052US12091410B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 17, 2024·0 cites·13 claims
- 2151US12071434B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Aug 27, 2024·0 cites·14 claims
- 2232US2017015654A1Pyridazine compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Keisuke Imamura files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →